| | 
Part, Chapter, Paragraph
1 II, 5. 3. 2| the former West Germany (1991), in the former East Germany (
2 II, 5. 3. 2| the former East Germany (1991), in Hungary (1992); moreover,
3 II, 5. 3. 6| major cancer sites during 1991–2002 (colorectal cancer
4 II, 5. 5. 3| episodes (Marneros et al, 1991). This can lead to significant
5 II, 5. 5. 3| Springer Verlag, Berlin 1991.~Mathers CD, Loncar D (2006):
6 II, 5. 5. 3| of cases (Berg & Shinnar, 1991). The difference between
7 II, 5. 5. 3| 1989 (*) /Maremmani et al., 1991 (*) /~Beghi et al., 1991 (*) /
8 II, 5. 5. 3| 1991 (*) /~Beghi et al., 1991 (*) /Giuliani et al., 1992 (*)~
9 II, 5. 5. 3| Ochoa Sangrador and Luaces, 1991 (*)~Spain ~Children >10
10 II, 5. 5. 3| 1019.~Berg AT, Shinnar S (1991): The risk of seizure recurrence
11 II, 5. 5. 3| 576.~Middleton LT, Dean G (1991): Multiple sclerosis in
12 II, 5. 5. 3| al, 1995; Granieri et al, 1991; Schrag and Quinn, 2000;
13 II, 5. 5. 3| studies (Granieri et al, 1991).~PD progresses relentlessly
14 II, 5. 5. 3| al, 1966; Granieri et al, 1991)). Standardisation of methodologies
15 II, 5. 5. 3| Monetti VC, De Bastiani P (1991): Parkinson’s disease in
16 II, 5. 6. 3| knee OA (Spector et al, 1991).~ ~The prevalence of OA
17 II, 5. 6. 3| national data were 0.1% of 1991 GNP, of which almost two-thirds
18 II, 5. 6. 3| age (van den Velden et al, 1991). New episodes are twice
19 II, 5. 6. 6| College of Rheumatology 1991 revised criteria for the
20 II, 5. 6. 6| DJ, and Leedham-Green M (1991): The prevalence of knee
21 II, 5. 6. 6| DH, Claessens AAMC et al (1991): Een Nationale Studie Naar
22 II, 5. 7. 3| 1000 patients with CKD in 1991. A similar finding in terms
23 II, 5. 8. 3| years) enrolled between 1991 and 1993 in 35 centres of
24 II, 5. 9. 2| 2004).~ ~ISAAC started in 1991. As many as 463 801 children
25 II, 5. 9. 3| Health Survey (ECRHS) in 1991–93 and had increased to
26 II, 5. 9. 4| was carried out during 1991-1993 in eight Swiss areas
27 II, 5. 10. 7| Respiratory Health Survey (ECRHS) 1991-1994. Eur J Clin Nutr 2001;
28 II, 5. 11. 1| medical disorders (Ryan et al, 1991).~Unlike most other medical
29 II, 5. 11. 3| 1994; Schmied and Saurat, 1991). Point prevalences of visible
30 II, 5. 11. 3| weeks of life (AA Fisher, 1991).~ ~Once an allergy to nickel
31 II, 5. 11. 3| dermatitis in children, Cutis, 1991;47(1):19-21.~Hasan T, Rantanen
32 II, 5. 11. 4| psychological well-being (Ryan, 1991). Disfiguring skin disease
33 II, 5. 11. 7| 1976;30:107–14.~ ~Ryan TJ (1991): Disability in Dermatology.
34 II, 5. 11. 7| Dermatology. Br J Hosp Med 1991;46:33–6.~ ~Royal College
35 II, 5. 11. 7| Schmied C, Saurat JH (1991): Epidemiology of atopic
36 II, 5. 11. 7| London: Springer-Verlag, 1991,9.~ ~Van Coevorden AM, Coenraads
37 II, 8. 2. 1| Leicestershire, based on 1991 data of the Leicestershire
38 II, 9 | neural tube defects (MRC, 1991) and probably a range of
39 II, 9. 1. 2| Neural Tube Defects~ ~In 1991, results of a randomised
40 II, 9. 1. 2| acid supplementation (MRC, 1991) established that raising
41 II, 9. 1. 2| neural tube defects (MRC, 1991), potentially more than
42 II, 9. 1. 2| Busby et al, 2005b; EUROCAT, 1991). During the 1990s, a shallow
43 II, 9. 1. 2| neural tube defects (MRC, 1991) and probably a range of
44 II, 9. 1. 2| EUROCAT Working Group (1991): "Prevalence of Neural
45 II, 9. 1. 2| Vitamin Study Research Group (1991): Prevention of neural tube
46 II, 9. 2. 5| Friendly Hospitals (UNICEF, 1991), and for the rights of
47 II, 9. 2. 7| Health, Helsinki.~ ~UNICEF (1991): The Baby-Friendly Hospital
48 III, 10. 1 | Dahlgren and Whitehead, 1991).~ ~Figure 10.1.1. The model
49 III, 10. 1. 1| Bondy, 1996; Pohorecky, 1991; Thakker, 1998). Alcohol
50 III, 10. 1. 1| Marshall, 1994; Miller et al, 1991; Miller et al, 1992; Sher,
51 III, 10. 1. 1| Sonne, 1999; Pohorecky, 1991).~ ~Figure 10.1.5. illustrates
52 III, 10. 1. 3| Dahlgren, G. & Whitehead, M. (1991): Policies and Strategies
53 III, 10. 1. 3| NS, Mahler JC, Gold MS (1991): Suicide risk associated
54 III, 10. 2. 1| consumption of wine, EU15, 1991-2004 (%)~ ~The latest average
55 III, 10. 2. 4| its Gentechnikgesetz from 1991 and countries like France
56 III, 10. 4. 3| Commission (European Commission, 1991). The target is to protect
57 III, 10. 4. 3| European Commission (1991): Directive 91/271/EC on
58 III, 10. 5. 3| increased, passing from 33% in 1991 to 44% in 2004, a confirmation
59 III, 10. 6. 2| Dahlgren and Whitehead (1991), social epidemiological
60 III, 10. 6. 2| Dahlgren, G. & Whitehead, M. (1991). Policies and Strategies
61 IV, 11. 1. 4| utilization (Mooney et al, 1991; Culyer et al, 1992; Mooney
62 IV, 11. 1. 6| Eisenhardt, 1989; Sappington, 1991). The combination of retrospective (
63 IV, 11. 6. 5| Mooney G, HallJ et al. (1991): "Utilisation as a measure
64 IV, 11. 6. 5| Policies.~ ~Sappington D (1991): "Incentives in Principal-Agent
65 IV, 12. 10 | waste” of 12th December 1991”.~o Presidential Degree
|
|
| |
